Project Goals

Create a program infrastructure to facilitate:

• Increased enrollment in early phase clinical trials for pediatric solid tumor patients

• Increased participation in biologic studies associated with early phase clinical trials

• Increased numbers of clinical trials and accelerate rapidity of their development, bringing novel agents and approaches from bench to bedside

• The development of a therapeutic I-MIBG program